MR Spectroscopy Using Normalized and Non-normalized Metabolite Ratios for Differentiating Recurrent Brain Tumor from Radiation Injury
- 30 September 2011
- journal article
- research article
- Published by Elsevier BV in Academic Radiology
- Vol. 18 (9), 1101-1108
- https://doi.org/10.1016/j.acra.2011.05.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injuryJournal of Neuro-Oncology, 2007
- Differentiation Between Brain Tumor Recurrence and Radiation Injury Using MR SpectroscopyAmerican Journal of Roentgenology, 2005
- Associations among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology with Special Attention to Radiation NecrosisNeurosurgery, 2004
- Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRINeuroradiology, 2002
- Variation of Post-treatment H-MRSI Choline Signal Intensity in Pediatric GliomasJournal of Neuro-Oncology, 1999
- Efficacy of Proton Magnetic Resonance Spectroscopy Inclinical Decision Making for Patients with Suspected Malignant Brain TumorsJournal of Neuro-Oncology, 1999
- Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapyJournal of Neurosurgery, 1997
- Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosisInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.Radiology, 1992